港股異動 | 創維集團(0751.HK)漲5% 前三季度純利增長40% 光伏業務收入大增27275%
格隆匯10月27日丨創維集團(0751.HK)漲5%,報2.52港元,總市值67億港元。創維集團發佈公吿,截至2021年9月30日止9個月,公司整體營業額為人民幣358.91億元,較去年同期增長33.2%;公司擁有人應占溢利7.63億元,同比增長40%;每股盈利29.01分。集團光伏業務收入錄得人民幣21.9億元,較去年同期大增27,275.0%。集團計劃以户用光伏開端,逐步開拓工商業光伏、用電側綜合智慧能源管理等業務,逐步發展成為用電側清潔能源產業互聯網的行業領導者。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.